Immuron Limited IMRN
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Revenue | 1.25M | 1.22M | 1.37M | 1.37M | 1.05M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 1.25M | 1.22M | 1.37M | 1.37M | 1.05M |
| Cost of Revenue | 428.80K | 419.20K | 502.30K | 500.70K | 379.40K |
| Gross Profit | 824.00K | 805.60K | 870.90K | 868.10K | 675.20K |
| SG&A Expenses | 1.42M | 1.39M | 1.24M | 1.24M | 1.31M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -296.70K | -290.00K | -109.70K | -109.30K | -245.10K |
| Total Operating Expenses | 1.82M | 1.78M | 2.02M | 2.01M | 1.96M |
| Operating Income | -565.30K | -552.70K | -647.50K | -645.50K | -902.60K |
| Income Before Tax | -625.10K | -611.10K | -629.80K | -627.80K | -873.50K |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -625.10K | -611.10K | -629.80K | -627.80K | -873.50K |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -625.10K | -611.10K | -629.80K | -627.80K | -873.50K |
| EBIT | -565.30K | -552.70K | -647.50K | -645.50K | -902.60K |
| EBITDA | -557.80K | -544.00K | -639.40K | -637.30K | -894.60K |
| EPS Basic | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Normalized Basic EPS | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| EPS Diluted | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Normalized Diluted EPS | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Average Basic Shares Outstanding | 320.16M | 320.16M | 274.03M | 274.03M | 233.35M |
| Average Diluted Shares Outstanding | 320.16M | 320.16M | 274.03M | 274.03M | 233.35M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |